Adherence [ftcn]
Anti-Hypertensive Agents [phsu]
Risk Reduction [inbe]
Renal Disease, End-Stage [dsyn]
Uncontrolled [qlco]
Hypertension [dsyn]
Associated [qlco]
Increased [qnco]
Risk [qlco]
Renal Disease, End-Stage [dsyn]
Blood Pressure [orgf]
Control [grup]
Slow progression [fndg]
Chronic kidney disease [dsyn]
IMPACT [gngm]
Antihypertensive agent [phsu]
Adherence [ftcn]
Prevention [topp]
Renal Disease, End-Stage [dsyn]
Never [tmco]
Evaluated [ftcn]
Assessed [acty]
IMPACT [gngm]
Antihypertensive agent [phsu]
Adherence [ftcn]
Risk [qlco]
Renal Disease, End-Stage [dsyn]
Patients [podg]
Databases [inpr]
Age [orga]
newly [idcn]
Diagnosed [fndg]
treated [topp]
Hypertension [dsyn]
Case Study [inpr]
Cohort [popg]
Design [acty]
To [qlco]
Assess [acty]
Risk [qlco]
Cox Models [inpr, qnco]
Proportional [qlco]
To [qlco]
Estimate [qnco]
Adjusted [ftcn]
Hazard Ratio [qnco]
Renal Disease, End-Stage [dsyn]
Adherence [ftcn]
Level [qlco]
Reported [inpr]
Medication [phsu]
possession [qnco]
Ratio [qnco]
Mean [qnco]
Age [orga]
Male [fndg]
diabetic [fndg]
Dyslipidaemia [dsyn]
Mean [qnco]
Follow-up [fndg]
High [qlco]
Adherence [ftcn]
Level [qlco]
More [ftcn]
Antihypertensive agent [phsu]
Compared [acty]
Lower [spco]
One [qnco]
Risk Reduction [inbe]
Renal Disease, End-Stage [dsyn]
Hazard Ratio [qnco]
Confidence Intervals [qnco]
Sensitivity [qnco]
Analysis [lbpr]
Revealed [qlco]
Effect [qlco]
Without [qlco]
Chronic kidney disease [dsyn]
risk factors [qnco]
Renal Disease, End-Stage [dsyn]
Male [fndg]
Diabetes [dsyn]
Peripheral Artery Disease [dsyn]
Chronic heart failure [dsyn]
Gout [dsyn]
Previous [tmco]
Chronic kidney disease [dsyn]
More [ftcn]
One [qnco]
Agent [chvf]
Study [mnob]
Suggest [idcn]
Better [qlco]
Adherence [ftcn]
Anti-Hypertensive Agents [phsu]
Risk Reduction [inbe]
Renal Disease, End-Stage [dsyn]
Adherence [ftcn]
Need [qlco]
To [qlco]
Improved [qlco]
To [qlco]
Benefits [qnco]
